Compounds > dactinomycin

dactinomycin and ursodeoxycholic acid

dactinomycin has been researched along with ursodeoxycholic acid in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Inaba, K; Ishikawa, H; Kashima, K; Matsumoto, M; Mitsuyoshi, H; Nakajima, Y; Nakashima, T; Okanoue, T; Sakamoto, Y	1
Campana, G; Di Toro, R; Murari, G; Spampinato, S	1

Reviews

1 review(s) available for dactinomycin and ursodeoxycholic acid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

6 other study(ies) available for dactinomycin and ursodeoxycholic acid

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes. Biochemical and biophysical research communications, 1997, Nov-26, Volume: 240, Issue:3 Topics: Animals; Biomarkers; Calcimycin; Cells, Cultured; Dactinomycin; Dexamethasone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Ionophores; Liver; Male; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Sphingosine; Tetradecanoylphorbol Acetate; Tyrosine Transaminase; Up-Regulation; Ursodeoxycholic Acid	1997
Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2000, Volume: 11, Issue:4 Topics: Bile Acids and Salts; Caco-2 Cells; Chenodeoxycholic Acid; Cholagogues and Choleretics; Dactinomycin; Dose-Response Relationship, Drug; Genes, fos; Humans; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; RNA, Messenger; Transcription, Genetic; Ursodeoxycholic Acid	2000